September 24, 2016 11:26 PM ET

Biotechnology

Company Overview of Afferent Pharmaceuticals, Inc.

Key Executives for Afferent Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Kathleen Sereda Glaub MBA23 RelationshipsChief Executive Officer and Director62
Anthony P. Ford Ph.D.No RelationshipsCo-Founder and Chief Scientific Officer--
Michael M. Kitt M.D.8 RelationshipsChief Medical Officer66

Afferent Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Kevin P. Starr 62 RelationshipsDecibel Therapeutics, Inc.53
Kathleen Sereda Glaub MBA 23 RelationshipsAfferent Pharmaceuticals, Inc.62
Liam Ratcliffe M.D., Ph.D. 66 RelationshipsNew Leaf Venture Partners, L.L.C.53
Jesse I. Treu Ph.D. 67 RelationshipsDomain Associates, L.L.C.69
Steven B. Abramson M.D. 29 RelationshipsNYU Langone Medical Center LLC--
View All Board Members

Afferent Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
383.9K
Bonus
263.7K
Total Short Term Compensation
478.9K
Total Value of Options
33.7M
Compensation as of Fiscal Year
Afferent Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

GlycoMimetics, Inc. Announces the Intention of Franklin H. Top to Resign as Directors Effective January 1, 2017
September 23, 2016 1:31 PM ET
Symic Bio Appoints Thomas N. Wight to Scientific Advisory Board
September 23, 2016 12:01 PM ET
Momenta Pharmaceuticals Inc. Appoints Corey N. Fishman to its Board of Directors
September 23, 2016 12:00 PM ET
uniQure N.V. Announces Management and Board Changes
September 22, 2016 8:18 PM ET
Ligand Pharmaceuticals Incorporated Announces Change of Principal Accounting Officer
September 22, 2016 8:06 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Afferent Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.